Randomized study to compare olmesartan + azelnidipine versus valsartan + amlodipine to maximize blood pressure control and organ protectio
Not Applicable
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000006605
- Lead Sponsor
- Kyoto Prefectural University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded from the study if there was any evidence of secondary hypertension, renal failure (serum creatinine≥2.0mg/dl), severe liver dysfunction, symptomatic heart failure, and past history of cerebral infarction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy of clinic and home blood pressure control
- Secondary Outcome Measures
Name Time Method CAVI(Cardio-Ankle Vascular Index)